Jill Henrich Atara Biotherapeutics, Inc. (ATRA) insider trading activity

ATRA Quotes by TradingView

Jill Henrich is EVP, Global Head RA & Quality of Atara Biotherapeutics, Inc.. Currently has a direct ownership of 20,378 shares of ATRA, which is worth approximately $181,567. The most recent transaction as insider was on Aug 16, 2024, when has been sold 963 shares (Common Stock) at a price of $6.63 per share, resulting in proceeds of $6,384. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.4K
96.15% 3M change
81.08% 12M change
Total Value Held $181,567

Jill Henrich Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 16 2024
SELL
Open market or private sale
$6,384 $6.63 p/Share
963 Reduced 4.51%
20,378 Common Stock
May 16 2024
SELL
Open market or private sale
$15,965 $0.62 p/Share
25,750 Reduced 4.64%
529,251 Common Stock
Mar 04 2024
SELL
Open market or private sale
$2,792 $0.72 p/Share
3,879 Reduced 0.69%
555,001 Common Stock
Jan 08 2024
BUY
Grant, award, or other acquisition
-
450,000 Added 44.6%
558,880 Common Stock
Nov 16 2023
SELL
Open market or private sale
$1,274 $0.39 p/Share
3,267 Reduced 3.03%
104,424 Common Stock
Aug 16 2023
SELL
Open market or private sale
$5,520 $1.65 p/Share
3,346 Reduced 3.01%
107,691 Common Stock
JH

Jill Henrich

EVP, Global Head RA & Quality
Thousand Oaks, CA

Track Institutional and Insider Activities on ATRA

Follow Atara Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATRA shares.

Notify only if

Insider Trading

Get notified when an Atara Biotherapeutics, Inc. insider buys or sells ATRA shares.

Notify only if

News

Receive news related to Atara Biotherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ATRA